Pharma News

Australia's Neurizon develops liquid formulation of NUZ-001 for treatment of Amyotrophic Lateral Sclerosis

Neurizon Therapeutics, a clinical-stage biotech company based in Australia, has announced the development of a

30 June, 2025 | Monday | News
SK Biosciences partners with PhnyX Lab to streamline drug discovery research using AI

South Korea-based SK Biopharm has signed a strategic Memorandum of Understanding (MoU) with AI corporation Phn

27 June, 2025 | Friday | News
Bayer extends partnership with Tsinghua University to accelerate pharma research in China

Bayer and Tsinghua University (THU) have announced the signing of the sixth phase of the collaboration agreeme

27 June, 2025 | Friday | News

BioTech News

SK bioscience completes expansion of new vaccine production facility in South Korea for global market

SK bioscience, a global innovative vaccine and biotech company based in South Korea, has secured a larg

30 June, 2025 | Monday | News
World's first HLA-G targeted exosome therapy for cancer by Taiwan enters US clinical trials

A research team led by Dr Der-Yang Cho, Superintendent of China Medical University Hospital (Taiwan), in colla

09 June, 2025 | Monday | News
Japanese startup RevolKa secures $1.4 M funding to advance therapeutic programmes

RevolKa Ltd., a venture-backed biotech company providing a cutting-edge artificial intelligence (AI)-driven pr

20 May, 2025 | Tuesday | News

MedTech News

ETT and Fujifilm extend access to innovative treatments for obesity in Middle East

Endo Tools Therapeutics (ETT), a Belgium-based company developing and marketing advanced endoscopic medic

01 July, 2025 | Tuesday | News
Medtech player Alcon expands manufacturing facility in Singapore

Alcon, the global leader in eye care, has announced the official opening of its expanded state-of-the-art manu

27 June, 2025 | Friday | News

BioServices News

China's WuXi Biologics launches next-generation platform for high-concentration biologics

WuXi Biologics, a leading global Contract Research, Development, and Manufacturing Organisation (CRDMO) in Chi

01 July, 2025 | Tuesday | News
Vetter invests $285 M in new clinical manufacturing site in US

Vetter, a globally operating Contract Development and Manufacturing Organisation (CDMO), recently celebrated t

30 June, 2025 | Monday | News

Inside Magazine

Medical Advances Soar With APAC’S CLINICAL TRIAL GROWTH
It’s a truth universally acknowledged that Asia-Pacific is a hotbed for clinical trials, with multiple reports confirming that it is the only region in the world to have seen a consistent surge in clinical trial activity. The Asia Pacific clinical trials market generated a revenue of $15.91 billion in 2023 and is expected to reach a projected revenue of $25.99 billion by 2030 at a compound annual growth rate of 7.3 per cent, according to the Grand View Research report. Between 2020 and 2025, China, India, Australia, Japan, South Korea, and Singapore emerged as key pillars of Asia-Pacific’s growing clinical trial ecosystem. Together, these six countries accounted for nearly 40,000 trials (39,843 in total). We take a close look at each country’s clinical trial landscape, examining who is leading in which phases, how domestic players compare to multinational sponsors, and which therapeutic areas are seeing the most activity. We also explore the challenges of running trials across such a diverse region.

Click here to access E-magazine

Video Gallery

Events

View All
01 - 02
Jul - 2025

Precision In Clinical Trials Summit Europe 2025

Precison Evolution Global

info@precision-globe.com https://events.precision-globe.com/single-event/precision-clinical-trials-summit-Zurich-europe

Inn Zurich, Switzerland

08 - 10
Jul - 2025

3rd ADC Toxicity Summit

Hanson Wade

info@hansonwade.com https://adc-toxicity.com/

Boston